Device
Sham-taVNS
Sham-taVNS is a medical device with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
completed240%
recruiting120%
unknown240%
Recent Activity
1 active trials
Showing 5 of 5
completednot_applicable
Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Acute Pancreatitis
NCT06998784
recruitingnot_applicable
Transcutaneous Auricular Vagus Nerve Stimulation as Adjuvant Treatment for Sepsis Patients
NCT07051694
unknownnot_applicable
Effect of taVNS on Heart Rate in Persistent Atrial Fibrillation
NCT05944575
completednot_applicable
Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome
NCT05392439
unknownnot_applicable
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Craving in Obese Individuals.
NCT03217929
Clinical Trials (5)
Showing 5 of 5 trials
NCT06998784Not Applicable
Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Acute Pancreatitis
NCT07051694Not Applicable
Transcutaneous Auricular Vagus Nerve Stimulation as Adjuvant Treatment for Sepsis Patients
NCT05944575Not Applicable
Effect of taVNS on Heart Rate in Persistent Atrial Fibrillation
NCT05392439Not Applicable
Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome
NCT03217929Not Applicable
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Craving in Obese Individuals.
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5